Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 1 September 2022 29 February 2024 29 February 2024 14351653 Mr A Rusdharry Mrs P D Rusdharry iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14351653 2022-08-31 14351653 2024-02-29 14351653 2022-09-01 2024-02-29 14351653 frs-core:CurrentFinancialInstruments 2024-02-29 14351653 frs-bus:PrivateLimitedCompanyLtd 2022-09-01 2024-02-29 14351653 frs-bus:FilletedAccounts 2022-09-01 2024-02-29 14351653 frs-bus:Micro-entities 2022-09-01 2024-02-29 14351653 frs-bus:AuditExempt-NoAccountantsReport 2022-09-01 2024-02-29 14351653 frs-bus:Director1 2022-09-01 2024-02-29 14351653 frs-bus:CompanySecretary1 2022-09-01 2024-02-29
Registered number: 14351653
Henley Healthcare Group Limited
Unaudited Financial Statements
For the Period 1 September 2022 to 29 February 2024
Balance Sheet
Registered number: 14351653
29 February 2024
£
Current assets 15,104
Prepayments and accrued income 2,000
Creditors: Amounts Falling Due Within One Year (4,749 )
NET CURRENT ASSETS 12,355
TOTAL ASSETS LESS CURRENT LIABILITIES 12,355
Accruals and deferred income (2,040 )
NET ASSETS 10,315
CAPITAL AND RESERVES 10,315

Notes

1. General Information
Henley Healthcare Group Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14351653 . The registered office is 32 Bosanquet Close, Uxbridge, Middlesex, UB8 3PE.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 7
7
Page 0
Page 1
For the period ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr A Rusdharry
Director
14th August 2024